AstraZeneca has published its first COVIDRIVE results in Lancet Regional Health Europe.

The study concluded that primary-series vaccination with AstraZeneca´s COVID-19 vaccine confers protection against COVID-19 hospitalisation with enduring levels of vaccine effectiveness through ≥6 months. Find out more here.

Leave a Reply

Your email address will not be published. Required fields are marked *